“These data demonstrate the therapeutic benefit of blocking Vegfa/Nrp1 interaction in the treatment of psoriatic disease, which may be safer for the treatment of psoriasis as compared to other therapeutic modalities that can be associated with serious side effects,” said Dr. Cédric Blanpain, the senior author of this study.
“Our initial finding that skin thickening in psoriasis is due to build-up of dysregulated stem cells and their progeny are exciting because it represents a new way of thinking about an old and significant skin disease.”
Findings from a survey distributed by the U.S. National Psoriasis Foundation show that many patients, unsatisfied with the results or side effects of their prescribed psoriasis treatments, are turning to complementary or alternative medicine.
A large new study has evaluated the risk of infection associated with various biologic therapies for patients with psoriasis finding that there was a significantly decreased risk with certain medications.
“It is critical for both patients and doctors to understand the complexity of psoriasis. It is not just a skin disease; it is a serious condition that can affect all aspects of a patient’s health,” says Randy Beranek, president and CEO of the NPF in a press release. “Our goal in establishing these guidelines is to help health care professionals educate their patients on the best way to treat their disease an...